Skip to content

Overview

Chinese Government donates 200,000 vaccines to Palestinian refugees through UNRWA

Commitments (Constant USD, 2023)$3,401,709
Commitment Year2022Country of ActivityMiddle East, regionalDirect Recipient Country of IncorporationMulti-RegionSectorHealthFlow TypeGrant

Status

Project lifecycle

Completion

Pipeline: PledgePipeline: CommitmentImplementationCompletion

Timeline

Key dates

Commitment date
Jan 1, 2022
End (actual)
Feb 24, 2022

Stakeholders

Organizations involved in projects and activities supported by financial and in-kind transfers from Chinese government and state-owned entities

Funding agencies

Government Agencies

  • China International Development Cooperation Agency (CIDCA)

Receiving agencies

Government Agencies

  • Government of Jordan
  • Government of Lebanon
  • Government of Syria

Intergovernmental Organizations

  • United Nations Agency for Palestinian Refugees (UNRWA)

Implementing agencies

Intergovernmental Organizations

  • United Nations Agency for Palestinian Refugees (UNRWA)

Loan description

Chinese Government donates 200,000 vaccines to Palestinian refugees through UNRWA

Narrative

Full Description

Project narrative

In early 2022, the Chinese government donated 200,000 Sinopharm COVID-19 vaccine doses to the United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA) for distribution to Palestinian refugees in Jordan, Syria, and Lebanon. As of February 24, 2022, the vaccine doses had been delivered by the UNRWA to the recipient countries.

Staff comments

1. 1. According to the UNICEF COVID-19 Vaccine Market Dashboard, the price of a single Sinopharm COVID-19 vaccine dose is $18 (https://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=DCD/DAC/STAT(2022)33&docLanguage=En). As such, AidData has estimated the monetary value of the 2022 donation as $3.6 million. 2. China International Development Cooperation Agency (CIDCA)'s logo appears in photos of the donation. As such, it is assumed CIDCA is the financier.